A 10-Year Cost-Effectiveness Analysis of Metabolic and Bariatric Surgery in Adolescents - Takeaways - MDSpire

A 10-Year Cost-Effectiveness Analysis of Metabolic and Bariatric Surgery in Adolescents

  • By

  • John B. Rode

  • Francesca Lim

  • Todd M. Jenkins

  • Justin R. Ryder

  • Thomas H. Inge

  • Chin Hur

  • Teen-LABS Consortium

  • Michael A. Helmrath

  • Anita P. Courcoulas

  • Marc P. Michalsky

  • Stephanie R. Sisley

  • Carroll M. Harmon

  • June 15, 2026

  • 0 min

Share

  • 1

    Pediatric obesity prevalence among children aged 2 to 18 years increased significantly from 2008 to 2023, with severe obesity rising by 44.5%.

  • 2

    Metabolic and bariatric surgery (MBS) has shown effective outcomes for adolescents, with average BMI reductions of 20.6% for Roux-en-Y gastric bypass and 19.2% for sleeve gastrectomy.

  • 3

    Remission rates for type 2 diabetes, hypertension, and dyslipidemia in adolescents after MBS range from 50% to 60%, highlighting its potential benefits.

  • 4

    Despite the efficacy of MBS, its adoption is limited due to concerns about upfront costs and the need for long-term cost-effectiveness data.

  • 5

    The study aims to evaluate the 10-year cost-effectiveness of RYGB and sleeve gastrectomy compared to no surgery for adolescents with severe obesity.

Original Source(s)

Related Content